SS

Stefan Stevanovic

IG Immatics Biotechnologies Gmbh: 1 patents #6 of 15Top 40%
LR Ludwig Institute For Cancer Research: 1 patents #1 of 30Top 4%
Overall (2016): #96,293 of 481,213Top 25%
2
Patents 2016

Issued Patents 2016

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
9498512 Powerful MHC-class II peptides derived from survivin Hans-Georg Rammensee, Cecile Gouttefanges, Toni Weinschenk, Peter Lewandrowski 2016-11-22
9469678 NY-ESO-1 peptides which bind to class II molecules and uses thereof Michael Pfreudschuh, Frank Neumann, Hans-George Rammensee 2016-10-18